Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
published in: Cancer Immunology Research
date of publication: 2016-12-06
main subject: immunotherapy, drug discovery
Cites articles
There is nothing here
Article - wd:Q51282620